The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study [0.03%]
糖尿病患者代谢综合征筛查的临床意义：横断面研究
Uditha Bulugahapitiya,Sajith Siyambalapitiya,Jabulani Sithole et al.
Uditha Bulugahapitiya et al.
The objectives of the study were to determine whether identifying patients with metabolic syndrome (MetS) (as defined by International Diabetes Federation [IDF] criteria) among patients with diabetes would affect the decision to prescribe s...
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men [0.03%]
循环可溶性CD36与糖耐量受损男性的葡萄糖代谢及白介素-6的关系
Aase Handberg,Abel Lopez-Bermejo,Judit Bassols et al.
Aase Handberg et al.
Recently, soluble CD36 (sCD36) levels were reported to be elevated in type 2 diabetes, and to be tightly correlated with insulin resistance. Our aim was to obtain further insight into the relationship between insulin sensitivity, low-grade ...
Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications [0.03%]
晚期糖基化终末产物受体(RAGE)和可溶性RAGE(sRAGE):心血管影响
Jason B Lindsey,Francesco Cipollone,Shuaib M Abdullah et al.
Jason B Lindsey et al.
Disorders of glucose metabolism are associated with increased risk for cardiovascular disease (CVD) complications, including coronary, peripheral and cerebral arterial disease, that account for the majority of morbidity and mortality among ...
Peter J Grant
Peter J Grant
Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment [0.03%]
他汀治疗患者中升高高密度脂蛋白胆固醇以降低残余心血管风险的临床意义
Terje R Pedersen,Gerd Assmann,Jean-Pierre Bassand et al.
Terje R Pedersen et al.
A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) Level 1 [0.03%]
1型糖尿病的国际并发症评估：DiaMond并发症子研究（DiaComp）第一阶段
Michael G Walsh,Janice Zgibor,Knut Borch-Johnsen et al.
Michael G Walsh et al.
The objectives of this study were to describe the global geographic variation of microvascular and macrovascular complications in childhood onset type 1 diabetes (T1D) and to relate any such variation to diabetes care activities such as sel...